Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus

被引:46
作者
Derksen, RHWM [1 ]
机构
[1] Univ Utrecht Hosp, Dept Rheumatol & Clin Immunol F02 126, NL-3508 GA Utrecht, Netherlands
关键词
dehydroepiandrosterone; DHEA(S); systemic lupus erythematosus;
D O I
10.1016/S0049-0172(98)80013-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study was performed to evaluate in vivo and in vitro data on the effects of the adrenal steroid dehydroepiandrosterone (DHEA) with emphasis on its potential use in the treatment of systemic lupus erythematosus (SLE). Methods: The literature dealing with DHEA was reviewed. Results: Initially, research on DHEA focused on effects of DHEA in relation to obesity. Over the past decade, research stimulated by associations between the physiological decline in DHEA and aging, cardiovascular disease, changes in metabolism, brain function, and immune senescense have generated insight into the many effects that DHEA or its metabolites may have. In SLE a role for sex hormones in both the etiopathogenesis and disease activity is recognized. in SLE, as in aging, low DHEA levels are frequently found, especially with corticosteroid treatment. Conclusions: Research data in the elderly, on both hormonal and immunologic effects, suggest that DHEA may become an adjunctive treatment for SLE patients. Copyright (C) 1998 by W.B. Saunders Company.
引用
收藏
页码:335 / 347
页数:13
相关论文
共 94 条
[1]   REVERSAL OF THE IMMUNOSENESCENT PHENOTYPE BY DEHYDROEPIANDROSTERONE - HORMONE-TREATMENT PROVIDES AN ADJUVANT EFFECT ON THE IMMUNIZATION OF AGED MICE WITH RECOMBINANT HEPATITIS-B SURFACE-ANTIGEN [J].
ARANEO, BA ;
WOODS, ML ;
DAYNES, RA .
JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) :830-840
[2]  
Barrera P, 1996, SEMIN ARTHRITIS RHEU, V25, P234, DOI 10.1016/S0049-0172(96)80035-7
[3]  
BARRETTCONNOR E, 1987, NEW ENGL J MED, V317, P711
[4]   A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE, MORTALITY, AND CARDIOVASCULAR-DISEASE [J].
BARRETTCONNOR, E ;
KHAW, KT ;
YEN, SSC .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1519-1524
[5]   A PROSPECTIVE-STUDY OF DEHYDROEPIANDROSTERONE SULFATE (DHEAS) AND BONE-MINERAL DENSITY IN OLDER MEN AND WOMEN [J].
BARRETTCONNOR, E ;
KRITZSILVERSTEIN, D ;
EDELSTEIN, SL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 137 (02) :201-206
[6]   Dehydroepiandrosterone (DHEA): A fountain of youth? [J].
Baulieu, EE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3147-3151
[7]   NEUROSTEROIDS - A NEW BRAIN-FUNCTION [J].
BAULIEU, EE ;
ROBEL, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (03) :395-403
[8]   Dehydroepiandrosterone reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen in men [J].
Beer, NA ;
Jakubowicz, DJ ;
Matt, DW ;
Beer, RM ;
Nestler, JE .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1996, 311 (05) :205-210
[9]   EFFECTS OF NITRENDIPINE ON GLUCOSE-TOLERANCE AND SERUM-INSULIN AND DEHYDROEPIANDROSTERONE SULFATE LEVELS IN INSULIN-RESISTANT OBESE AND HYPERTENSIVE MEN [J].
BEER, NA ;
JAKUBOWICZ, DJ ;
BEER, RM ;
AROCHA, IR ;
NESTLER, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :178-183
[10]   THE CALCIUM-CHANNEL BLOCKER AMLODIPINE RAISES SERUM DEHYDROEPIANDROSTERONE SULFATE AND ANDROSTENEDIONE, BUT LOWERS SERUM CORTISOL, IN INSULIN-RESISTANT OBESE AND HYPERTENSIVE MEN [J].
BEER, NA ;
JAKUBOWICZ, DJ ;
BEER, RM ;
NESTLER, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) :1464-1469